FLO Form 4/A: 7,900 deferred shares granted to director
Rhea-AI Filing Summary
Flowers Foods, Inc. director Sterling A. Spainhour Jr. reported an amended Form 4 showing a grant of 7,900 deferred shares dated 10/01/2025 under the 2014 Omnibus Equity and Incentive Compensation Plan (amended May 25, 2023). The deferred shares carry no conversion or exercise price and are recorded as representing 7,900 underlying common shares beneficially owned following the transaction. The record shows a date listed as exercisable on 05/21/2026 and a note indicating no expiration date. The filing was amended to add a confirming statement and is signed by an agent on 10/06/2025.
Positive
- 7,900 deferred shares granted to a director, increasing alignment with shareholders
- No exercise/conversion price on the deferred shares, indicating conversion without additional cash
- Amendment adds confirming statement to clarify the reported transaction
Negative
- None.
Insights
Director received deferred equity as standard board compensation.
Granting 7,900 deferred shares to a director is a non‑cash compensation method that aligns the director’s interests with shareholders by tying value to common stock ownership rather than immediate cash payout. The award is granted under the company’s 2014 Omnibus Equity and Incentive Compensation Plan (amended 05/25/2023), which is the stated vehicle for director awards.
The filing notes the deferred shares have no exercise/conversion price and a listed exercisable date of 05/21/2026 while also stating no expiration date, which removes time pressure on conversion. Monitor board compensation disclosures in proxy statements for frequency and aggregate director equity to assess governance trends over the next proxy cycle.
This amendment confirms deferred share details and ownership post‑grant.
The statement records the award as deferred stock with 7,900 underlying common shares beneficially owned following the transaction, which is treated as a non‑derivative holding for the reporting person. The disclosure that the deferred shares have $0 exercise price is explicit and implies the award converts to common stock without additional payment when vesting or distribution conditions are met.
Key items to watch are the timing or triggers for distribution and any related tax elections, which are not detailed here; those specifics typically appear in plan documents or subsequent disclosures and will determine near‑term shareholder dilution and tax timing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock | 7,900 | $0.00 | $0.00 |
Footnotes (3)
- F1. Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023).
- F2. In accordance with the terms of the Flowers Foods, Inc. Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price.
- F3. No expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
